Sarina Tanimoto

Sarina Tanimoto discloses dealings in ARS Pharmaceuticals, Inc. to SEC (Form 4). Between 8 November 2022 and 19 August 2025, the trades on record add up to 31 filings.

On the market, this insider has only sold: 26 sales, €8.9M in total. The rest of the record consists of 1 share grant and 3 option exercises. Since January 2025: no purchases and 1 sale on the market.

Most recently, on 21 August 2025, the filings show an open-market sale worth €149k in ARS Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.